共查询到20条相似文献,搜索用时 31 毫秒
1.
Shin Fujita Seiichiro Yamamoto Takayuki Akasu Yoshihiro Moriya 《International journal of colorectal disease》2009,24(9):1085-1090
Background To clarify the risk factors of lateral pelvic lymph node (LPLN) metastasis of rectal cancer, we examined associations between
LPLN status and clinicopathological factors including LPLN status diagnosed by computed tomography (CT).
Methods We reviewed a total of 210 patients with advanced rectal cancer, of which the lower margin was located at or below the peritoneal
reflection, who underwent preoperative CT with 5-mm-thick sections and lateral pelvic lymph node dissection at the National
Cancer Center Hospital between February 1998 and March 2006.
Results Forty-seven patients (22.4%) had LPLN metastasis. Multivariate analysis showed that LPLN status diagnosed by CT, pathological
regional lymph node status, tumor location, and tumor differentiation were significant risk factors for LPLN metastasis. Among
45 patients with well-differentiated adenocarcinoma who were LPLN-negative and in whom CT had found no regional lymph node
metastasis, none had LPLN metastasis. On the other hand, among 13 patients with moderate or less differentiated lower rectal
adenocarcinoma who were LPLN-positive and in whom CT had revealed regional lymph node metastasis, 12 (92.3%) had LPLN metastasis.
Conclusions LPLN status diagnosed by CT, pathological regional LN status, tumor location, and tumor differentiation are significant risk
factors for LPLN metastasis. Using these factors, patients can be classified as having a low or high risk of LPLN metastasis. 相似文献
2.
Wu ZY Wan J Li JH Zhao G Yao Y Du JL Liu QF Peng L Wang ZD Huang ZM Lin HH 《World journal of gastroenterology : WJG》2007,13(45):6048-6052
AIM: To evaluate the risk factors for lateral lymph node metastasis in patients with advanced low rectal cancer, in order to make the effective selection of patients who could benefit from lateral lymph node dissection, as well as the relationship of lateral lymph node metastasis with local recurrence and survival of patients with advanced low rectal cancer. METHODS: A total of 96 consecutive patients who underwent curative surgery with lateral pelvic lymphadenectomy for advanced lower rectal cancer were retrospectively analyzed. The relation of lateral lymph node metastasis with clinicopathologic characteristics, local recurrence and survival of patients was identified. RESULTS: Lateral lymph node metastasis was observed in 14.6% (14/96) of patients with advanced low rectal cancer. Lateral lymph node metastasis was detected in 10 (25.0%) of 40 patients with tumor diameter ≥ 5 cm and in 4 (7.1%) of 56 patients with tumor diameter 〈 5 cm. The difference between the significant (X^2 = 5.973, P = two groups was statistically 0.015). Lateral lymph node metastasis was more frequent in patients with 4/4 diameter of tumor infiltration (7 of 10 cases, 70.0%), compared with patients with 3/4, 2/4 and 1/4 diameter of tumor infiltration (3 of 25 cases, 12.0%; 3 of 45 cases, 6.7%; 1 of 16 cases, 6.3%) (X^2 = 27.944, P = 0.0001). The lateral lymph node metastasis rate was 30.0% (9 of 30 cases), 9.1% (4 of 44 cases) and 4.5% (1 of 22cases) for poorly, moderately and well-differentiated carcinoma, respectively. The difference between the three groups was statistically significant (X^2 = 8.569, P = 0.014). Local recurrence was 18.8% (18 of 96 cases), 64.3% (9 of 14 cases), and 11.0% (9 of 82 cases) in patients with advanced low rectal cancer, in those with and without lateral lymph node metastasis, respectively. The difference between the two groups was statistically significant (X^2 = 22.308, P = 0.0001). Kaplan-Meier survival analysis showed significant impr 相似文献
3.
Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer 总被引:26,自引:0,他引:26
Sugihara K Kobayashi H Kato T Mori T Mochizuki H Kameoka S Shirouzu K Muto T 《Diseases of the colon and rectum》2006,49(11):1663-1672
Purpose This study was designed to clarify indication and benefit of pelvic sidewall dissection for rectal cancer.
Methods The retrospective, multicenter study collected the data of rectal cancer patients who underwent surgery between 1991 and 1998
and were prospectively followed.
Results Of 1,977 patients with rectal cancers, 930 underwent pelvic sidewall dissection without adjuvant radiotherapy. Positive lateral
lymph nodes were found in 129. Multivariate analysis disclosed a significantly increased incidence of positive lateral lymph
nodes in female gender, lower rectal cancers, non-well-differentiated adenocarcinoma, tumor size of ≥4 cm and T3-T4. The five-year
survival rate for 1,977 patients was 79.7 percent. The survival of patients with positive lateral lymph nodes was significantly
worse than that of Stage III patients with negative lateral lymph nodes (45.8 vs. 71.2 percent, P<0.0001). Multivariate analysis showed significantly worse prognosis in male gender, pelvic sidewall dissection, lower rectal
cancers, T3-T4, perirectal lymph node metastasis, and positive lateral lymph nodes. During the median follow-up time of 57 months,
recurrence developed in 19.7 percent: 17 percent in negative and 58.1 percent in positive lateral lymph nodes (P<0.0001). Local recurrence was found in 8 percent: 6.8 percent in negative and 25.6 percent in positive lateral lymph nodes
(P<0.0001). Multivariate analysis disclosed that lower rectal cancers, non-well-differentiated adenocarcinoma, T3-T4, perirectal
lymph node metastasis, and positive lateral lymph nodes were significantly associated with an increased local recurrence.
Conclusions Positive lateral lymph node was the strongest predictor in both survival and local recurrence. Pelvic sidewall dissection
may be indicated for patients with T3-T4 lower rectal cancers because of the greater provability of positive lateral lymph
nodes.
Study Group for Rectal Cancer Surgery of the Japanese Society for Cancer of the Colon and Rectum.
Presented at the United States-Japan Clinical Trial Summit Meeting, Maui, Hawaii, February 10–13, 2005. 相似文献
4.
直肠淋巴流向的研究从1895年D. Gerota的研究开始,提出了直肠淋巴流向可以分为上、中、下三个方向,经过很多学者的进一步研究修正,现普遍认为侧方淋巴流向可以分为4个方向:1.前方,由膀胱下动脉,前列腺动脉,经闭孔动脉到髂总动脉;2.沿直肠中动脉到髂内动脉;3.沿着骶中动脉和骶外侧动脉到腹主动脉分叉部位;4.沿着直肠下动脉到髂内动脉。侧方淋巴结转移主要发生在低位直肠癌,浸润深度大于肌层者,而转移的侧方淋巴结并不包括在直肠癌全直肠系膜切除术(TME)范围之内。NCCN直肠癌诊疗指南中没有提及侧方淋巴结的概念,日本大肠癌规约则认为有适应证的低位直肠癌应行侧方淋巴结清扫术。西方学者认为直肠癌侧方淋巴结转移是全身疾病,侧方淋巴结清扫难以改善总体临床结局;日本学者则认为是局部疾病,对低位直肠癌规范手术为TME+侧方淋巴结清扫。西方学者认为术前放化疗可替代侧方淋巴结清扫;东方学者则认为对于术前放化疗不敏感的直肠癌患者,侧方淋巴结清扫术仍不失为一个可供选择的治疗方案。低位直肠癌患者是否应行预防性盆腔侧方淋巴结清扫仍存在争议,但治疗性侧方淋巴结清扫术则是日本的直肠癌规范治疗。不少研究报道了腹腔镜侧方淋巴结清扫术的初步探索结果,认为其是安全有效的,但其与开放手术的远期肿瘤学结果对比仍需多中心随机对照研究验证。 相似文献
5.
Seung-Joo Nam Byung Chang Kim Hee Jin Chang Han Ho Jeon Junho Kim Su Young Kim 《Gut and liver》2022,16(2):228
Background/AimsSmall rectal neuroendocrine tumors (NETs) are often managed with local resection (endoscopic or transanal excision) owing to their low risk of metastasis and recurrence. However, the clinical significance of lymphovascular invasion in resected specimens remains controversial. In this study, we aimed to analyze the frequency of and risk factors for lymph node metastasis proven by histopathologic examination after radical resection.MethodsWe retrospectively reviewed the records of 750 patients diagnosed with a rectal NET at four academic medical centers in South Korea between 2001 and 2019. The frequency of histopathologically proven lymph node metastasis and the associated risk factors were analyzed for small tumors (≤1.5 cm) with lymphovascular invasion.ResultsAmong 750 patients, 75 had a small tumor (≤1.5 cm) with lymphovascular invasion, of whom 31 patients underwent endoscopic resection only and 44 patients underwent additional radical surgery. Among the 41 patients who underwent surgery and had available data, the rate of regional lymph node metastasis was 48.8% (20/41). In multivariate analysis, the Ki-67 index (odds ratio, 6.279; 95% confidence interval, 1.212 to 32.528; p=0.029) was an independent risk factor for lymph node metastasis. During the mean follow-up period of 37.7 months, only one case of recurrence was detected in the surgery group. The overall survival was not significantly different between radical resection and local resection (p=0.332).ConclusionsRectal NETs with lymphovascular invasion showed a significantly high rate of regional lymph node metastasis despite their small size (≤1.5 cm). 相似文献
6.
M. Ishii M. Ota S. Saito Y. Kinugasa S. Akamoto I. Ito 《International journal of colorectal disease》2009,24(9):1069-1074
Objective When selecting patients who are at high risk for lymph node metastasis, the detection of lymphatic vessel invasion (LVI) is
important. We investigated LVI detected by D2-40 staining as a predictor of lymph node metastasis in T1 colorectal cancer.
Materials and methods Clinicopathological factors including LVI were investigated in 136 patients who underwent colectomy with lymph node dissection
for T1 colorectal cancer. We used immunostaining with monoclonal antibody D2-40 to detect LVI.
Results Lymph node metastases were found in 18 patients (13.2%), and LVI were detected in 45 (33%); lymph node metastasis was more
frequently observed in LVI-positive groups (13/45 vs 5/91, p < 0.001). Both univariate and multivariate analyses revealed that LVI detected by D2-40 and a poorly differentiated histology
at the invasion front were independent risk factors of lymph node metastasis.
Conclusion LVI detected by D2-40 is important for the prediction of lymph node metastasis. 相似文献
7.
Hara M Hirai T Nakanishi H Kanemitsu Y Komori K Tatematsu M Kato T 《International journal of colorectal disease》2007,22(8):911-917
BACKGROUND AND AIMS: The aim of this study was to determine the incidence of isolated tumor cells (ITC) and micrometastasis in lateral lymph nodes of patients with rectal cancer and its possible correlation with prognosis. MATERIALS AND METHODS: One hundred seventy-seven rectal cancer patients who underwent curative resection with lateral lymph node dissection were enrolled. Dissected lymph nodes were examined using hematoxylin-eosin staining (HE) and immunohistochemistry (IHC) with anti-keratin antibody (AE1/AE3). States of lymph node metastasis were divisible into three groups: detectable with HE (HE+), detectable with only IHC (HE-/IHC+), and undetectable even with IHC (IHC-). Almost all the HE-/IHC+ group was classified as ITC consisting of a few tumor cells according to the UICC criteria (ITC+). Survival rates were compared among HE+, ITC+, and IHC-. RESULTS: ITC+ were detected in 24.1% of patients with HE-negative lateral lymph nodes. No significant difference in overall 5-year survival was observed between ITC+ and IHC- patients (76.1 and 82.9%, respectively, p = 0.25). Multivariate analysis showed that perirectal HE+ lymph nodes, but not ITC+ lateral lymph nodes, was an independent prognostic factor. CONCLUSIONS: ITC in lateral lymph nodes does not contribute to the prognosis of rectal cancer in patients who undergo extended lateral lymph node dissection, unlike HE+ lateral lymph node metastasis. 相似文献
8.
Jong Hee Hyun Seong Dae Lee Eui Gon Youk Jae Bum Lee Enu-Jung Lee Hee Jin Chang Dae Kyung Sohn 《World journal of gastroenterology : WJG》2015,21(47):13302-13308
AIM: To validate the association between atypical endoscopic features and lymph node metastasis(LNM).METHODS: A total of 247 patients with rectal neuroendocrine tumors(NETs) were analyzed. Endoscopic images were reviewed independently by two endoscopists, each of whom classified tumors by sized and endoscopic features, such as shape, color, and surface change(kappa coefficient 0.76 for inter-observer agreement). All of patients underwent computed tomography scans of abdomen and pelvis for evaluation of LNM. Univariate and multivariate analyses were performed to identify the factors associated with LNM. Additionally, the association between endoscopic atypical features and immunohistochemical staining of tumors was analyzed.RESULTS: Of 247 patients, 156(63.2%) were male and 15(6.1%) were showed positive for LNM. On univariate analysis, tumor size(P 0.001), shape(P 0.001), color(P 0.001) and surface changes(P 0.001) were significantly associated with LNM. On multivariate analysis, tumor size(OR = 11.53, 95%CI: 2.51-52.93, P = 0.002) and atypical surface(OR = 27.44, 95%CI: 5.96-126.34, P 0.001) changes were independent risk factors for LNM. The likelihood of atypical endoscopic features increased as tumor size increased. Atypical endoscopic features were associated with LNM in rectal NETs 10 mm(P = 0.005) and 10-19 mm(P = 0.041) in diameter. Immunohistochemical staining showed that the rate of atypical endoscopic features was higher in non L-cell tumors.CONCLUSION: Atypical endoscopic features as well as tumor size are predictive factors of LNM in patients with rectal NETs. 相似文献
9.
Size analysis of lymph node metastasis in esophageal cancer: diameter distribution and assessment of accuracy of preoperative diagnosis 总被引:1,自引:0,他引:1
Yoshiaki Kajiyama Yoshimi Iwanuma Natsumi Tomita Takayuki Amano Fuyumi Isayama Toshiharu Matsumoto Masahiko Tsurumaru 《Esophagus》2006,3(4):189-195
Background In esophageal cancer, lymphatic spread occurs more frequently and at an earlier stage than in other gastrointestinal cancers,
and both preoperative and intraoperative diagnoses of lymph nodes metastases are sometimes incorrect. Our objective was to
measure the sizes of lymphatic metastases and to examine the accuracy of clinical diagnosis of lymphatic spread in patients
with squamous cell carcinoma of the esophagus.
Methods The sizes of 320 metastatic lymph nodes of 9254 dissected nodes from 92 consecutive esophagectomy patients over 1 year were
measured and compared with the sizes of the actual metastases within the nodes. These data allowed investigation of the correct
rate of preoperative diagnosis of lymph node metastasis.
Results The mean diameter of the metastases was 4.8 mm, which was significantly smaller than that of the involved lymph nodes. Among
the metastatic lymph nodes, 37.2% were less than 5 mm in diameter, and 63.1% of the metastases were less than 5 mm in diameter.
The true-positive and true-negative diagnosis rate for all lymph node stations in three fields (neck, thorax, and abdomen)
was only 23.2%, and the false-negative rate for diagnosis of lymph node metastasis was 53.7%.
Conclusions Two-thirds of involved lymph nodes had very small metastases (<5 mm), suggesting that limited confidence should be placed
in the preoperative diagnosis of lymphatic spread. Therefore, extensive lymph node dissection appears appropriate in esophageal
cancer surgery, given the small sizes of many metastases and the difficulty with preoperative diagnosis. 相似文献
10.
《Pancreatology》2020,20(5):936-943
BackgroundVarious studies have reported inconsistent results regarding the use of lymph node size for the prediction of metastasis in pancreatic cancer. Further, there is even less information in pNENs. Thus, the clinical accuracy and utility of using lymph node size to predict lymph node metastasis in pNENs has not been fully elucidatedObjectivesThis study aimed to examine differences in lymph node morphology between pancreatic neuroendocrine neoplasms (pNENs) and pancreatic ductal adenocarcinomas (PDACs) to create more accurate diagnostic criteria for lymph node metastasis.MethodsWe assessed 2139 lymph nodes, 773 from pNEN specimens and 1366 from PDAC specimens, surgically resected at our institute between 1994 and 2016. We evaluated the number, shape, size, and presence of metastasis.ResultsSixty-eight lymph nodes from 16 pNEN patients and 109 lymph nodes from 33 PDAC patients were metastatic. There were more lymph nodes sampled per case in the PDAC group than in the pNEN group (31.8 vs. 18.0). Metastatic lymph nodes in pNEN patients were larger and rounder than those in PDAC patients (minor axis: 5.15 mm vs. 3.11 mm; minor axis/major axis ratio: 0.701 vs. 0.626). The correlation between lymph node size and metastasis was stronger in pNENs (r = 0.974) than in PDACs (r = 0.439).ConclusionsLymph node status and morphology are affected by differences in tumor histology. The lymph node minor axis is a reliable parameter for the prediction of lymph node metastasis and has more utility as a predictive marker in pNENs than in PDACs. 相似文献
11.
Dae Gon Ryu Su Jin Kim Cheol Woong Choi Dae Hwan Kang Hyung Wook Kim Su Bum Park Hyeong Seok Nam Si Hak Lee Sun Hwi Hwang 《Medicine》2022,101(37)
The management of gastroduodenal neuroendocrine tumor (NET) has been controversial between radical surgical resection and local excision including endoscopic resection. A gastroduodenal NET grade (G), measured by their mitotic rate and Ki67 proliferation index, is important to predict prognosis. In this study, we aimed to compare the clinical outcomes of gastroduodenal NET according to grades in order to identify poor prognostic factors of gastroduodenal NETs. Fifty-four gastroduodenal NETs diagnosed between December 2008 and December 2020 in a tertiary referral hospital were retrospectively reviewed. The clinical outcomes of gastroduodenal NETs, according to tumor grades and factors associated with NET G2-3, were analyzed. A total of 52 gastroduodenal NET patients was enrolled. The mean follow-up period was 56.2 ± 40.1 months. The mean size of gastric and duodenal NET was 7.9 ± 11.0 mm and 9.8 ± 7.6 mm, respectively. During the study period, 72.7% (16/22) of gastric NETs and 83.3% (25/30) of duodenal NETS were G1. All G1 gastroduodenal NETs showed no lymph node or distant metastasis during the study periods. All G3 gastroduodenal NETs showed metastasis (one lymph node metastasis and 3 hepatic metastases). Among metastatic NETs, the smallest tumor size was a 13 mm gastric G3 NET. Factors associated with G2-3 NETs were larger tumor size, mucosal ulceration, proper muscle or deeper invasion, and lymphovascular invasion. A small-sized gastroduodenal NET confined to submucosa without surface ulceration may be suitable for endoscopic resection. After local resection of a gastroduodenal NET (G1) without lymphovascular and muscle proper invasion, follow-up examination without radical surgical resection can be recommended. G3 NETs may be treated by radical surgical resection, regardless of tumor size. 相似文献
12.
Joonsung Choi Soon Nam Oh Dong-Myung Yeo Won Kyung Kang Chan-Kwon Jung Sang Woo Kim Michael Yong Park 《World journal of gastroenterology : WJG》2015,21(2):556-562
AIM: To assess the role of computed tomography(CT) and magnetic resonance imaging(MRI) and establish imaging criteria of lymph node metastasis in early colorectal cancer.METHODS: One hundred and sixty patients with early colorectal cancer were evaluated for tumor location, clinical history of polypectomy, depth of tumor invasion, and lymph node metastasis. Two radiologists assessed preoperative CT and/or MRI for the primary tumor site detectability, the presence or absence of regional lymph node, and the size of the largest lymph node. Demographic, imaging, and pathologic findings were compared between the two groups of patients based on pathologic lymph node metastasis and optimal size criterion was obtained.RESULTS: The locations of tumor were ascending, transverse, descending, sigmoid colon, and rectum. One hundred and sixty early colorectal cancers were classified into 3 groups based on the pathological depth of tumor invasion; mucosa, submucosa, and depth unavailable. A total of 20(12.5%) cancers with submucosal invasion showed lymph node metastasis. Lymph nodes were detected on CT or MRI in 53 patients. The detection rate and size of lymph nodes were significantly higher(P = 0.000, P = 0.044, respectively) in patients with pathologic nodal metastasis than in patients without nodal metastasis. Receiver operating curve analysis showed that a cut-off value of 4.1 mm is optimal with a sensitivity of 78.6% and specificity of 75%.CONCLUSION: The short diameter size criterion of≥ 4.1 mm for metastatic lymph nodes was optimal for nodal staging in early colorectal cancer. 相似文献
13.
Steffen Alexander Wedel Jon Jones Igor Tsaur Wolf-Dietrich Beecken Dietger Jonas Roman Blaheta Hanns Ackermann 《The American journal of the medical sciences》2010,339(4):341-344
IntroductionIn this study, we aimed to determine those clinical and pathologic features that are associated with pelvic lymph node metastasis in patients with transitional cell cancer of the bladder. Unlike previous studies, we particularly focused on intravesical tumor location.MethodsWe included 173 patients who underwent radical cystectomy and bilateral pelvic lymphadenectomy for muscle-invasive or high-risk superficial bladder cancer. Fifty patients (28.9%) presented with lymph node metastases. Tumor-related and personal characteristics were analyzed.ResultsLymph node positive disease occurred in association with an increasing pathologic tumor stage (P < 10? 6) and with a decreasing differentiation status (P = 0.008). The rate of pelvic lymph node metastasis differed in primary tumors growing on different intravesical locations. Cancers located exclusively on the lateral bladder walls (P < 10? 5) and tumors involving the lateral walls (P = 0.042) were highly correlated with lymph node positive disease. Posterior wall tumors were least associated with lymph node metastases compared with other tumor locations (P = 0.015). Focal tumor growths located on the lateral bladder wall and an increasing pathologic tumor stage and decreasing differentiation-status were identified as independent risk factors for the pelvic lymph node status.ConclusionsFor the first time we present the association of intravesical tumor location and the rate of lymph node metastasis in transitional cell cancer of the bladder. Our findings may ultimately contribute to a more individualized patient management. 相似文献
14.
《Pancreatology》2021,21(5):884-891
BackgroundPancreatic ductal adenocarcinoma can directly invade the peripancreatic lymph nodes; however, the significance of direct lymph node invasion is controversial, and it is currently classified as lymph node metastasis. This study aimed to identify the impact of direct invasion of peripancreatic lymph nodes on survival in patients with pancreatic ductal adenocarcinoma.MethodsA total of 411 patients with resectable/borderline resectable pancreatic ductal adenocarcinoma who underwent pancreatic resection at two high-volume centers from 2006 to 2016 were evaluated retrospectively.ResultsSixty (14.6%) patients had direct invasion of the peripancreatic lymph nodes without isolated lymph node metastasis (N-direct group), 189 (46.0%) had isolated lymph node metastasis (N-met group), and 162 (39.4%) had neither direct invasion nor isolated metastasis (N0 group). There was no significant difference in median overall survival between the N-direct group (35.0 months) and the N0 group (45.6 month) (p = 0.409), but survival was significantly longer in the N-direct compared with the N-met group (25.0 months) (p = 0.003). Similarly, median disease-free survival was similar in the N-direct (21.0 months) and N0 groups (22.7 months) (p = 0.151), but was significantly longer in the N-direct compared with the N-met group (14.0 months) (p < 0.001). Multivariate analysis identified resectability, adjuvant chemotherapy, and isolated lymph node metastasis as independent predictors of overall survival. However, direct lymph node invasion was not a predictor of survival.ConclusionDirect invasion of the peripancreatic lymph nodes had no effect on survival in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma, and should therefore not be classified as lymph node metastasis. 相似文献
15.
As 18F-fluorodeoxyglucose (FDG) is taken up by inflammatory lymph nodes, it could be falsely interpreted as metastasis. Therefore,
we evaluated the diagnostic ability of positron emission tomography/computed tomography (PET/CT) for lymph node staging of
lung cancer when inflammatory lung disease coexisted. Patients with operable non-small-cell lung cancer and FDG-avid lymph
nodes were retrospectively classified into two groups; those with inflammatory lung disease (ILD) and those without it (NILD).
Receiver operating characteristic (ROC) curve analysis was performed for maximum standardized uptake value (SUVmax), pattern
of FDG uptake, maximum Hounsfield unit, and size, and then the areas under the ROC curves (AUCs) were compared between subgroups.
There were 124 patients (ILD/NILD = 38/86) and 396 FDG-avid lymph nodes (ILD/NILD = 140/256). The average number of FDG-avid
lymph nodes was greater in ILD (3.7 vs. 2.9, p = 0.039), whereas the proportion of metastasis was higher in NILD (25.4% vs. 11.4%, p = 0.002). With all N1–N3 lymph nodes and the NILD group, the AUC values of all four parameters were significantly greater
than 0.5 (p < 0.05), and SUVmax was the most valuable parameter for lymph node metastasis. However, in the ILD group, only the AUC value
of SUVmax was significantly greater than 0.5. These results were reproduced when analyses were performed with N1–N2 lymph
nodes. In conclusion, SUVmax was the most valuable PET/CT parameter for assessment of lymph node metastasis in patients with
operable non-small-cell lung cancer. In addition, it was the only valuable parameter when inflammatory lung disease coexisted. 相似文献
16.
Nobuyoshi Takeshita Toru Fukunaga Masayuki Kimura Yuji Sugamoto Kentaro Tasaki Isamu Hoshino Takumi Ota Tetsuro Maruyama Tomohide Tamachi Takashi Hosokawa Yo Asai Hisahiro Matsubara 《World journal of gastroenterology : WJG》2015,21(44):12722-12728
A 66-year-old female presented with the main complaint of defecation trouble and abdominal distention. With diagnosis of rectal cancer, c SS, c N0, c H0, c P0, c M0 c Stage Ⅱ, Hartmann's operation with D3 lymph node dissection was performed and a para-aortic lymph node and a disseminated node near the primary tumor were resected. Histological examination showed moderately differentiated adenocarcinoma, p SS, p N3, p H0, p P1, p M1(para-aortic lymph node, dissemination) f Stage Ⅳ. After the operation, the patient received chemotherapy with FOLFIRI regimen. After 12 cycles of FOLFIRI regimen, computed tomography(CT) detected an 11 mm of liver metastasis in the posteroinferior segment of right hepatic lobe. With diagnosis of liver metastatic recurrence, we performed partial hepatectomy. Histological examination revealed moderately differentiated adenocarcinoma as a metastatic rectal cancer with cut end microscopically positive. After the second operation, the patient received chemotherapy with TS1 alone for 2 years. Ten months after the break, CT detected a 20 mm of paraaortic lymph node metastasis and a 10 mm of lymph node metastasis at the hepato-duodenal ligament. With diagnosis of lymph node metastatic recurrences, we performed lymph node dissection. Histological examination revealed moderately differentiated adenocarcinoma as metastatic rectal cancer in paraaortic and hepato-duodenal ligament areas. After the third operation, we started chemotherapy with modified FOLFOX6 regimen. After 2 cycles of modified FOLFOX6 regimen, due to the onset of neutropenia and liver dysfunction, we switched to capecitabine aloneand continued it for 6 mo and then stopped. Eleven months after the break, CT detected two swelling 12 mm of lymph nodes at the left supraclavicular region. With diagnosis of Virchow lymph node metastatic recurrence, we started chemotherapy with capecitabine plus bevacizumab regimen. Due to the onset of neutropenia and hand foot syndrome(Grade 3), we managed to continue capecitabine administration with extension of interval period and dose reduction. After 2 years and 2 mo from starting capecitabine plus bevacizumab regimen, Virchow lymph nodes had slowly grown up to 17 mm. Because no recurrence had been detected besides Virchow lymph nodes for this follow up period, considering the side effects and quality of life, surgical resection was selected. We performed left supraclavicular lymph node dissection. Histological examination revealed moderately differentiated adenocarcinoma as a metastatic rectal cancer. After the fourth operation, the patient selected follow up without chemotherapy. Now we follow up her without recurrence and keep her quality of life high. 相似文献
17.
Tiffet O Kaczmarek D Chambonnière ML Guillan T Baccot S Prévot N Bageacu S Bourgeois E Cassagnau E Lehur PA Dubois F 《Diseases of the colon and rectum》2007,50(7):962-970
Purpose This study was designed to assess the feasibility of a combined colorimetric and radioisotopic technique in the detection
of the sentinel lymph node in colorectal cancer.
Methods This prospective dual-center study included 64 patients. Using endoscopy on D0, a radiolabeled colloid was injected into the
peritumoral submucosa, followed by a lymphoscintigraphy. Intraoperatively, on D1, lymphatic mapping was performed by using
a visual method and radioguided detection after subserosal peritumoral injection of patent blue. Twenty-nine patients were
injected only with the patent blue, 18 patients only with the radioactive tracer, and the other 17 patients benefited from
both techniques.
Results The detection rate was 92 percent. The average number of sentinel nodes harvested was 2.8. Twenty-four of 59 patients were
pN+ (40 percent) and in 12 cases the sentinel lymph node was histologically negative, although there was a positive nonsentinel
node (false-negative rate, 50 percent). The false-negative rate for the combined, radioisotopic, and colorimetric techniques
were 63, 60, and 36 percent, respectively. In four patients, the sentinel node was the only metastatic site (4/24, 17 percent),
and in two of these four patients, the sentinel lymph node presented with micrometastases (<2 mm). The radioisotopic technique
allowed us to highlight a lateral drainage of two rectal cancers (2/13, 15 percent). The concordance between the blue and
radioactive sentinel nodes was 43 percent.
Conclusions The addition of a radioisotopic method using submucosal injection does not improve the false-negative rate. The sentinel lymph
node technique in colorectal cancer is feasible, although the false-negative rate is such that the technique should still
be considered as experimental.
Supported by the “H?pital Universitaire de Saint Etienne” and by a grant from the French Ministry of Research (PHRC national
2001).
Presented at the Congrès Fran?ais de Chirurgie, Paris, France, September 27 to 30, 2005. 相似文献
18.
Mayer S zur Hausen A Watermann DO Stamm S Jäger M Gitsch G Stickeler E 《Journal of cancer research and clinical oncology》2008,134(11):1229-1235
Purpose CD44 is a cell surface glycoprotein involved in cell–cell and cell–substrate interactions, which may be shed or released into
circulation by proteolytic enzymatic mechanisms. Alternative splicing of CD44 and aberrant levels of soluble CD44 variants
in the serum of cancer patients have been correlated to tumor progression and metastasis in different tumors including breast
cancer. In this study we evaluated the clinical value of CD44 serum levels (sCD44) in patients with primary breast cancer.
Methods Concentrations of soluble isoforms sCD44std, sCD44v5 and sCD44v6 were determined with a sensitive ELISA and normalized against
the total protein concentration (TP). Pre-operative serum samples from 82 patients and 67 age-matched healthy blood donors
were analyzed. The results were correlated to clinico-pathological parameters (tumor size, grading, lymph node metastasis,
etc.).
Results In sera of breast cancer patients, we detected elevated concentrations of sCD44v6 (P = 0.0001) and total protein TP (P = 0.0001) in comparison to healthy controls, whereas overall sCD44 (sCD44std) and sCD44v5 did not differ. Patients with sCD44v6-concentrations
above the 75%-percentile showed an increased T stage (2.9 cm vs. 1.8 cm) as well as a higher risk for lymph node metastasis
(55% vs. 35%). In breast cancer patients with lymph node metastasis the median value of sCD44v6 was significantly higher (P = 0.025) in comparison to patients without lymph node metastasis and healthy controls.
Conclusions Our data suggest an upregulated expression of alternatively spliced soluble CD44 isoforms in breast cancer patients. The specific
alterations of certain CD44 isoform concentrations (especially sCD44v6) may reflect disturbances of the nuclear splicing machinery
in tumor cells. The clinical significance of our findings are underlined by the positive correlation of elevated sCD44v6 concentrations
and lymph node metastases (r
s = 0.25). 相似文献
19.
104例直肠癌患者淋巴结转移情况及其相关因素分析 总被引:3,自引:0,他引:3
目的探讨影响直肠癌患者淋巴结转移的相关因素,为临床诊断、治疗和预后评估提供参考。方法回顾性分析104例手术治疗的直肠腺癌患者的临床病理资料,对可能与其淋巴结转移有关的因素进行单因素和多因素Logistic回归分析。结果本组淋巴结转移率为45.19%;肿瘤分化程度低、浸润程度深及第二号人表皮生长因子受体(C-erbB-2)表达阳性者淋巴结转移率显著升高(P〈0.05),三者均为影响直肠癌患者淋巴结转移的重要因素,尤以C-erbB-2表达为著(P〈0.05)。结论直肠癌淋巴结转移与肿瘤浸润深度、分化程度和C-erbB-2表达密切相关,尤以C-erbB-2表达为著;临床对相关患者应于术中尽可能彻底清除引流区域内的淋巴结、术后进行积极辅助性治疗,以减少术后复发、提高生存率。 相似文献
20.